Literature DB >> 19332849

Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.

Mitsuru Takeuchi1, Shigeru Sasaki, Masato Ito, Shinsuke Okada, Satoru Takahashi, Tatsuya Kawai, Kaori Suzuki, Hidekazu Oshima, Masaki Hara, Yuta Shibamoto.   

Abstract

PURPOSE: To prospectively evaluate the ability of diffusion-weighted (DW) magnetic resonance (MR) imaging to be used to determine the T stage of bladder cancer and to measure the correlation between the apparent diffusion coefficient (ADC) and histologic grade.
MATERIALS AND METHODS: This study was approved by the local institutional review board. All patients gave written informed consent. Forty patients with a total of 52 bladder tumors underwent MR imaging that included DW imaging. Histologic grade was determined for all tumors. Two radiologists interpreted four image sets (ie, T2-weighted images alone, T2-weighted plus DW images, T2-weighted plus dynamic contrast agent-enhanced images, all three image types together). Conventional criteria were used for interpreting T2-weighted and contrast-enhanced images. For DW images, new staging criterion developed on the basis of the hypothesis that tumors, submucosal tissue, and muscles show high, low, and intermediate signal intensity, respectively, was used. The McNemar test was used to examine differences in accuracy, sensitivity, and specificity. Differences in the performance were analyzed by comparing the areas under the receiver operating characteristic curves (A(z) values). To compare ADCs between three histologic grades, analysis of variance was used.
RESULTS: The overall accuracy of T stage diagnosis was 67% for T2-weighted images alone, 88% for T2-weighted plus DW images, 79% for T2-weighted plus contrast-enhanced images, and 92% for all three image types together. The overall accuracy, specificity, and A(z) for diagnosing T2 or higher stages were significantly improved by adding DW images (P < .01). The mean ADC of G3 tumors was significantly lower than that of G1 and G2 tumors (P < .01).
CONCLUSION: DW images provided useful information for evaluating the T stage of bladder cancer, particularly in differentiating T1 or lower tumors from T2 or higher tumors. The ADC may in part predict the histologic grade of bladder cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19332849     DOI: 10.1148/radiol.2511080873

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  65 in total

1.  Radiomics assessment of bladder cancer grade using texture features from diffusion-weighted imaging.

Authors:  Xi Zhang; Xiaopan Xu; Qiang Tian; Baojuan Li; Yuxia Wu; Zengyue Yang; Zhengrong Liang; Yang Liu; Guangbin Cui; Hongbing Lu
Journal:  J Magn Reson Imaging       Date:  2017-02-15       Impact factor: 4.813

2.  Imaging: does DW-MRI have a role in the evaluation of hematuria?

Authors:  David Galvin; Bernard H Bochner
Journal:  Nat Rev Urol       Date:  2009-09       Impact factor: 14.432

3.  The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions.

Authors:  S Avcu; M N Koseoglu; K Ceylan; M D Bulut; M Dbulutand; O Unal
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

4.  [Oncological diseases and postoperative alterations of the bladder and urinary tract].

Authors:  M M Ong; P Riffel; J Budjan; C Bolenz; S O Schönberg; S Haneder
Journal:  Radiologe       Date:  2014-12       Impact factor: 0.635

5.  Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.

Authors:  Minsu Lee; Su-Jin Shin; Young Taik Oh; Dae Chul Jung; Nam Hoon Cho; Young Deuk Choi; Sung Yoon Park
Journal:  Eur Radiol       Date:  2017-02-06       Impact factor: 5.315

6.  Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report.

Authors:  Soichiro Yoshida; Shuichiro Kobayashi; Fumitaka Koga; Junichiro Ishioka; Chikako Ishii; Hiroshi Tanaka; Yasukazu Nakanishi; Yoh Matsuoka; Noboru Numao; Kazutaka Saito; Hitoshi Masuda; Yasuhisa Fujii; Kazunori Kihara
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

7.  Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Staging of Bladder Cancer.

Authors:  Elham Rabie; Fariborz Faeghi; Mohammad-Hossein Izadpanahi; Mohammad-Ali Dayani
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 8.  Current Status of Hybrid PET/MRI in Oncologic Imaging.

Authors:  Andrew B Rosenkrantz; Kent Friedman; Hersh Chandarana; Amy Melsaether; Linda Moy; Yu-Shin Ding; Komal Jhaveri; Luis Beltran; Rajan Jain
Journal:  AJR Am J Roentgenol       Date:  2015-10-22       Impact factor: 3.959

Review 9.  Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract.

Authors:  Alberto Diaz de Leon; Daniel Costa; Ivan Pedrosa
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

Review 10.  DW-MRI of the urogenital tract: applications in oncology.

Authors:  G Petralia; H C Thoeny
Journal:  Cancer Imaging       Date:  2010-10-04       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.